Cash and Short Term Investments (Annual) Chart

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1995. Start Trial.
Date Value
September 30, 2026 332.95M
September 30, 2025 343.28M
September 30, 2024 433.26M
September 30, 2023 1.022B
September 30, 2022 1.953B
September 30, 2021 234.65M
September 30, 2020 254.27M
September 30, 2019 339.30M
September 30, 2018 243.99M
September 30, 2017 101.65M
September 30, 2016 85.12M
September 30, 2015 150.74M
September 30, 2014 162.24M
September 30, 2013 129.05M
September 30, 2012 141.05M
September 30, 2011 125.82M
Date Value
September 30, 2010 108.83M
September 30, 2009 88.03M
September 30, 2008 143.35M
September 30, 2007 248.33M
September 30, 2006 184.05M
September 30, 2005 324.02M
September 30, 2004 255.37M
September 30, 2003 129.48M
September 30, 2002 150.65M
September 30, 2001 203.83M
September 30, 2000 219.24M
September 30, 1999 66.37M
September 30, 1998 68.16M
September 30, 1997 71.75M
September 30, 1996 2.102M
September 30, 1995 15.59M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Bionano Genomics, Inc. 29.54M
Agilent Technologies, Inc. 1.789B
Bio-Rad Laboratories, Inc. 1.543B
Bruker Corp. 298.80M
Danaher Corp. 4.615B